6,9-DISUBSTITUTED PURINE DERIVATIVES AND THEIR USE FOR TREATING SKIN
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61389030%3A_____%2F16%3A00464747" target="_blank" >RIV/61389030:_____/16:00464747 - isvavai.cz</a>
Result on the web
<a href="https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20160510&DB=EPODOC&locale=en_EP&CC=CA&NR=2657516C&KC=C&ND=5" target="_blank" >https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20160510&DB=EPODOC&locale=en_EP&CC=CA&NR=2657516C&KC=C&ND=5</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
6,9-DISUBSTITUTED PURINE DERIVATIVES AND THEIR USE FOR TREATING SKIN
Original language description
The present invention provides methods and compositions for countering the adverse effects of aging on mammalian cells in vitro and in vivo, especially human skin cells and human skin, and treatment of hyperproliferative and related skin diseases in mammals by administering compositions containing 6,9-disubstituted purine derivatives.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
CE - Biochemistry
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
CA2657516
Publisher
CA001 -
Publisher name
Canadian Intellectual Property Office (CIPO)
Place of publication
Gatineau, Québec
Publication country
CA - CANADA
Date of acceptance
May 10, 2016
Owner name
Ústav experimentální botaniky AV ČR, v. v. i.
Method of use
B - Výsledek je využíván orgány státní nebo veřejné správy
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence